Added to YB: 2024-02-19
Pitch date: 2024-02-16
INMD [neutral]
InMode Ltd.
-33.57%
current return
Author Info
Atmos Invest shares company deep dives and investing process deep dives. Sign up for the newsletter.
Company Info
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.
Market Cap
$943.7M
Pitch Price
$21.57
Price Target
N/A
Dividend
N/A
EV/EBITDA
3.83
P/E
6.51
EV/Sales
1.11
Sector
Health Care Equipment and Supplies
Category
turnaround
Inmode Update: Beautiful devices and nasty lawsuits
INMD Q4: 8% YoY growth, 84% gross margin, but lawsuit alleges misleading pricing & FDA issues. No buybacks despite ROIC>WACC. EPS +22% even with sales decline. Concerns on discounting & compliance, but still profitable. 2024 pivotal with lawsuit & Classys rivalry. Thesis intact barring negatives.
Read full article (7 min)